BANAN

LOE Approaching

cefpodoxime proxetil

NDAORALFOR SUSPENSION
Approved
Aug 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4

Clinical Trials (4)

NCT01907308Phase 2Withdrawn

Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma

Started Feb 2014
0
Urothelial Carcinoma
NCT01555268Phase 1Completed

Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

Started Oct 2011
24 enrolled
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more
NCT01281254Phase 3Terminated

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

Started Apr 2011
223 enrolled
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer
NCT02525536Phase 1Completed

A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors

Started Jun 2009
18 enrolled
Neoplasms, Advanced Solid